Disruptive Pharma AB
Important Dates
Disruptive Pharma AB's next confirmed earnings release is scheduled for November 12, 2026.
| Earnings Date | 11/12/2026 |
Share Statistics
As of March 31, 2026, Disruptive Pharma AB has 44.82M shares outstanding.
| Shares Outstanding | 44.82M |
Financial Position
As of March 31, 2026, Disruptive Pharma AB maintains a current ratio of 2.14, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.14 |
| Quick Ratio | 1.52 |
Income Statement
SEKThese figures cover the twelve months ended March 31, 2026.
| Pretax Income | -3.37M |
Balance Sheet
SEKThese figures are as of March 31, 2026. Total book value stands at 3.47M, with working capital of 3.05M providing operational flexibility.
| Cash & Cash Equivalents | 4.08M |
| Net Debt | -4.08M |
| Equity (Book Value) | 3.47M |
| Book Value Per Share | 0.08 |
| Working Capital | 3.05M |
Cash Flow
SEKThese figures cover the twelve months ended March 31, 2026.
| Free Cash Flow | -3.64M |
| FCF Per Share | -0.08 |
Margins
These figures cover the twelve months ended March 31, 2026. The operating margin of -575.38 and net profit margin of -572.84 provide insight into operational efficiency.
| Operating Margin | -575.38 |
| Pretax Margin | -572.84 |
| Profit Margin | -572.84 |
Stock Splits
Disruptive Pharma AB's most recent stock split took place on March 17, 2025.
| Last Split Date | 3/17/2025 |